AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Features


Liquid biopsy entered a new era in August with FDA’s approval of two tests that use next-generation sequencing to target many genes in advanced cancer patients.
Over the last decade, several new acute kidney injury biomarkers have gained regulatory approval for human testing in different countries, with some being limited in U.S. clinical labs.

Ask the Expert


Bench Matters


Federal Insider


Industry Playbook


Regulatory Roundup


Special Supplement


This year’s unique, all-virtual 2020 AACC Annual Scienti¬fic Meeting & Clinical Lab Expo will be an energizing platform for attendees to share their labs’ stories, hear about others’ experiences, and catch up with the evolving science around not only SARS-CoV-2 testing but also all other areas of lab medicine.

The Sample